Stock Chart
RAPT
Type: SELL wallstreet
Strike: $60
Premium: $0.05
Expiry: Jan 15, 2027
Target: $58
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About RAPT - RAPT Therapeutics, Inc. Common Stock
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Key Statistics
More RAPT Analysis
This RAPT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RAPT's price movements with trendlines, gamma walls, and key support/resistance levels.